SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining ($CIFR) is trending due to a recently announced AI hosting deal with Google-backed Fluidstack, sparking both excitement and concern within the investment community. While the deal secures substantial revenue and Google's backing, an $800 million convertible note offering has fueled dilution fears, leading to a sell-off despite the long-term potential of the company's pivot towards AI data centers and community conviction.

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.

SciSparc Ltd

Scisparc Ltd

SPRC is experiencing high volatility and trading volume amid news regarding its merger with AutoMax Motors, leading to community discussions about potential short squeezes and price targets. Traders are reacting to the recent court stay on the merger, with some anticipating further upward momentum while others remain cautious due to the company's financials and past dilution history. The stock's low float and high short interest are also contributing to the intense speculation.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as the stock experiences a green day, sparking excitement among investors who are discussing potential short squeezes and government support. Community members are debating the impact of a recent large private investment and the possibility of further billionaire involvement. The rise is also attributed to broader sector momentum and speculation surrounding upcoming news and permits.

China Natural Resources, Inc. is an investment holding company. The firm is primarily involved in the exploration and mining in the People’s Republic of China (PRC). It is engaged in the exploration for lead, silver, and other metals, and copper trading in the Inner Mongolia Autonomous Region of the PRC. The company was founded on December 14, 1993 and is headquartered in Hong Kong.

China Natural Resources Inc

CHNR is trending as traders discuss its potential as a lithium play following news of a planned acquisition in Zimbabwe. Community members are pointing to the stock's low float and speculating about a possible short squeeze, anticipating a significant price increase. Overall interest seems to be rising, with many expressing bullish sentiment.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics ($CAPR) is trending due to anticipation surrounding their DMD drug, Deramiocel, and the FDA's regulatory flexibility regarding the HOPE-3 trial data, expected in mid-Q4. Community discussions revolve around the potential for accelerated approval and a possible short squeeze, while some express concern over trial endpoints and cash runway. Bullish sentiment highlights the drug's potential impact on both muscle and heart decline in DMD patients.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending due to a Jefferies upgrade and raised price target, sparking renewed interest among investors. The community is discussing the potential for a breakout, referencing a CNBC interview, and comparing it to similar plays like Lithium Americas. Broader sector tailwinds, including government interest in rare earth and lithium production, are contributing to the positive sentiment.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as community members discuss its recent partnership with Boeing to integrate AI across defense programs, with some analysts boosting price targets. Bullish investors see this as a major deal, while bearish traders express concerns about high valuations and insider selling. The stock's volatile price action and potential for a breakout or pullback are also being heavily debated.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending amidst reports of a potential investment from Apple, fueling speculation about a major turnaround for the chipmaker. The community is buzzing about potential partnerships and what it could mean for Intel's market position, especially with government backing and previous investments from Nvidia.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to a new agreement with OpenAI, valued at $6.5 billion, driving significant interest and discussion around the company's role in AI infrastructure. Community members are actively debating the stock's volatility and potential direction, with some expressing optimism about future growth and others pointing to intraday price swings and potential manipulation. The broader context involves CoreWeave's close ties to Nvidia and its position within the rapidly expanding AI sector.

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

PepGen Inc

PEPG is trending due to positive trial results for its DM1 drug, sparking optimism about its Enhanced Delivery Oligonucleotide platform; however, a recently announced public offering of shares is generating mixed sentiment. The community is actively debating whether the potential dilution will overshadow the promising clinical data, or if a short squeeze could drive the price higher.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Mission Produce Outperform Amid Soft Produce Demand?

AVO posts record $357.7M revenues on higher avocado volumes, global sourcing strength and expanding international sales.

AVO Bets on Direct-to-Retail in Europe: Too Soon or Just Right?

Mission Produce is pushing deeper into Europe with direct-to-retail deals as avocado demand climbs and sales surge 37% YoY in Q3 2025.

Is Mission Produce's International Farming Finally Bearing Fruit? 

AVO's International Farming strategy delivers impressive results, and drives record growth, stronger profitability and an expanding presence in global markets.

Is Mission Produce Ready to Deliver on Global Sourcing Hopes?

AVO posts record $380.3 million revenues as it expands beyond avocados into mangos and blueberries, leveraging its global sourcing strength.

Can AVO's Supply Chain Integration Drive Stability in Uncertain Times?

Mission Produce's global sourcing and multi-crop strategy drive record revenues, but high valuation and profit headwinds linger.

 Are Supply Chain Wins Enough to Fuel AVO's Next Growth Phase?

Mission Produce's supply chain agility and category expansion into mangoes and blueberries fuel momentum beyond avocados.

Can Mission Produce Handle Margin Pressures From Mexico Supply?

AVO faces margin strain due to early supply issues in Mexico, but leverages global sourcing to stabilize operations.

Is Mission Produce's Vertical Model a Long-Term Margin Driver?

AVO's vertical integration drives 28% revenue growth and positions it for long-term margin expansion and global scale.

Volume Up, Price Down: Can AVO Balance Growth With Profitability?

Mission Produce ramps up avocado, mango and blueberry volumes to meet global demand. However, falling prices test its margins.

Mission Produce Rides on Price Volatility: Can it Sustain Growth?

AVO posts 29% revenue jump on high-priced avocados and expanding fruit sales. However, margins face pressure from rising costs.

Calavo Growers, Inc. engages in the marketing and distribution of avocados, prepared avocado products, and other perishable foods. It operates through the Grown and Prepared segments. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment includes all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa. The company was founded in 1924 and is headquartered in Santa Paula, CA.

Calavo Growers, Inc

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Stocktwits

Costco Wholesale Corp

) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Current Price	$26.20
Prev Close	$26.29
Open	$26.35
Dividend Yield	1.88%
50-Day Moving Average	$27.08
Beta	0.50
Avg. Volume	162,497.52
PE Ratio	29.99

52-Week High	$30.02
52-Week Low	$21.46
Market Capitalization	$469.36M
EPS (Annual)	-$0.0712
Price to Book	2.27
Revenue Per Employee	$314,123.46
Enterprise Value/EBITDA	N/A

CVGW
Calavo Growers, Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CVGW News

CVGW Calavo Growers, Inc